首页> 外文期刊>Chemical engineering journal >Evaluation of ferrate as a coagulant aid/oxidant pretreatment for mitigating submerged ultrafiltration membrane fouling in drinking water treatment
【24h】

Evaluation of ferrate as a coagulant aid/oxidant pretreatment for mitigating submerged ultrafiltration membrane fouling in drinking water treatment

机译:评估高铁酸盐作为减轻饮用水处理中超滤膜深层结垢的助凝剂/氧化剂预处理

获取原文
获取原文并翻译 | 示例
       

摘要

Although pre-coagulation can mitigate ultrafiltration (UF) membrane fouling in the treatment of surface waters for drinking water supply, biological activities ('biofouling') can induce a continuous increase in membrane fouling. To meet this challenge, potassium ferrate, K2FeO4, a combined oxidant and coagulant, was evaluated as a pre-treatment chemical for controlling submerged UF membrane fouling in water treatment. Ferrate use as an alternative to- (phase 1: similar to 23 days), and in combination with- (phase 2: similar to 30 days), conventional FeCl3, have been studied using parallel continuous bench-scale submerged membrane systems, using FeCl3 as the reference. The poorer performance of ferrate (alone) as a pre-treatment compared to FeCl3 (phase 1) was the result of a lower coagulation efficiency, which outweighed the beneficial impact of the ferrate on bacterial inactivation. The net reduction in pre-treatment performance led to an increase in the concentration of residual, active bacteria in the membrane tank, and bacteria associated large molecular weight (MW) organic substances, such as extra cellular polymeric substances (EPS) or biopolymers, which were the principal cause of the higher rate of membrane fouling observed. In contrast, ferrate performed best as a coagulant aid/oxidant (FeCl3/K2FeO4) (phase 2), with the rate of membrane fouling (increase in transmembrane pressure) 4.5 times lower than conventional FeCl3 pre-treatment. This pre-treatment arrangement resulted in less bacteria (and EPS) and suspended solids in the membrane tank, and less accumulation of materials in the cake layer and within the membrane pores. The results indicated clearly the potential benefit of applying ferrate as a coagulant aid/oxidant with a coagulant, in UF pre-treatment, with the control of bacteria and EPS a key factor in reducing membrane fouling. (C) 2016 Elsevier B.V. All rights reserved.
机译:尽管预凝结可以减轻饮用水处理地表水中的超滤(UF)膜结垢,但是生物活性(“生物结垢”)可以导致膜结垢的持续增加。为了应对这一挑战,评估了高铁酸钾,K2FeO4(一种氧化剂和凝结剂)作为一种预处理化学品,用于控制水处理中的浸入式超滤膜结垢。高铁酸盐替代-(阶段1:相似,为期23天),并与-(阶段2:相似,为期30天)组合使用传统的FeCl3,已经通过平行连续的台式规模浸没膜系统进行了研究,使用FeCl3作为参考。与FeCl3(阶段1)相比,高铁酸盐(单独)作为预处理的性能较差是凝结效率较低的结果,这超过了高铁酸盐对细菌灭活的有益影响。预处理性能的净降低导致膜罐中残留的活性细菌和与细菌相关的大分子量(MW)有机物质(例如细胞外聚合物(EPS)或生物聚合物)的浓度增加。是观察到的更高的膜污染率的主要原因。相反,高铁酸盐作为凝结助剂/氧化剂(FeCl3 / K2FeO4)(阶段2)表现最好,其膜结垢率(跨膜压力增加)比传统的FeCl3预处理低4.5倍。这种预处理安排减少了膜罐中的细菌(和EPS)和悬浮固体,并减少了滤饼层和膜孔内的物料堆积。结果清楚地表明,在超滤预处理中,将高铁酸盐作为凝结助剂/氧化剂与凝结剂一起使用具有潜在的益处,而细菌和EPS的控制是减少膜结垢的关键因素。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号